Alkem Laboratories Limited

Eli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec

It did not take long for predictions of higher-priced merger-and-acquisition activity in 2025 to come true as Johnson & Johnson’s proposed $14.6bn buyout of Intra-Cellular and its rising neuropsyc

2023 has brought with it some big-ticket patent expiries on the Indian market. Even as twists and turns around the patent battle pertaining to Novartis ’s heart-failure therapy Entresto (sacubitril/v

2023 has brought with it some big-ticket patent expiries on the Indian market. Even as twists and turns around the patent battle pertaining to Novartis AG ’s heart-failure therapy Entresto (sacubitri